Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
Orchestra BioMed has raised $35.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2026.
Orchestra BioMed's investors include Perceptive Advisors, RTW Investments, Medtronic, Soleus Capital, Ligand Pharmaceuticals.
Orchestra BioMed is headquartered in New Hope, United States.
Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
Orchestra BioMed is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orchestra BioMed — Funding & Investors." VCBacked, May 6, 2026, https://www.vcbacked.co/company/orchestra-biomed. Accessed July 21, 2026.
VCBacked. (2026). Orchestra BioMed — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/orchestra-biomed
{{cite web |title=Orchestra BioMed — Funding & Investors |url=https://www.vcbacked.co/company/orchestra-biomed |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated